Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
A broad clinical spectrum of PLCepsilon1-related kidney disease and intrafamilial variability.
Yılmaz EK, Saygili S, Gulhan B, Canpolat N, Bayazıt AK, Kilic BD, Akıncı N, Benzer M, Goknar N, Tufan AK, Kalyoncu M, Nalcacioglu H, Tekcan D, Yıldız G, Agbas A, Nayır A, Topaloglu R, Caliskan S, Ozaltin F.
Pediatr Nephrol. 2022 Aug;37(8):1855-1866. doi: 10.1007/s00467-021-05371-7. Epub 2022 Jan 16.
PMID:35034193
The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity.
Hesselink DA, Bouamar R, van Gelder T.
Ther Drug Monit. 2010 Aug;32(4):387-93. doi: 10.1097/FTD.0b013e3181e44244.